Pharma and BiotechUS FDA Eases Informed Consent for Minimal Risk Clinical Trials Posted on 8th February 202417th February 2024 by RegASK FDA Implements 21st Century Cures Act: Effective 30 days post-publication, ensuring rights and safety of human subjects. The final rule amendment allows exceptions for informed consent in minimal-risk clinical investigations. Read More Regulatory Intelligence Support FDA Proposes Human Abuse Potential Study for Kratom FDA Guidance on Developing Chimeric Antigen Receptor (CAR) T Cell Products Published